Back

Treatment cessation of dual antiplatelet therapy after percutaneous coronary intervention and clinical events during follow-up

15 June 2016 (09:00 - 17:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Posters Group 2 Cardiac rehabilitation, models and methods ESC Premium Access EuroPRevent Meeting 2016

About the speaker

Photo
Doctor Manuel Marina Breysse

Idoven, Madrid (Spain)

10 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Miss S. Lim (Singapore, SG)
Abstract
Presentation thumbnail
Doctor T. Ravnikar (Izola, SI)
Abstract
Presentation thumbnail
Miss S. Ozberk (Izmir, TR)
Abstract
Presentation thumbnail
Miss N. Oji (London, GB)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Posters Group 2

The Event

Event poster

EuroPRevent Meeting 2016

15 June 2016 09:00 CET
You may be interested in
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Thirty-days versus standard duration of dual antiplatelet treatment after percutaneous coronary interventions: a systematic review and meta-analysis
27 August 2022
thumbnail
Congress Presentation
Perioperative risk and benefit of antiplatelet therapy in patients undergoing non-cardiac surgery within 1 year after percutaneous coronary intervention with second-generation drug-eluting stents.
27 August 2022
thumbnail
Congress Presentation
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome and multivessel coronary artery disease: a post-hoc analysis of the TROPICAL-ACS trial
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources